首页> 美国卫生研究院文献>Veterinary Research >Oral immunization with a novel attenuated Salmonella Gallinarum encoding infectious bronchitis virus spike protein induces protective immune responses against fowl typhoid and infectious bronchitis in chickens
【2h】

Oral immunization with a novel attenuated Salmonella Gallinarum encoding infectious bronchitis virus spike protein induces protective immune responses against fowl typhoid and infectious bronchitis in chickens

机译:新型减毒沙门氏菌编码传染性支气管炎病毒刺突蛋白的口服免疫可诱导鸡对家禽伤寒和传染性支气管炎的保护性免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fowl typhoid (FT), a septicemic disease caused by Salmonella Gallinarum (SG), and infectious bronchitis (IB) are two economically important avian diseases that affect poultry industry worldwide. Herein, we exploited a live attenuated SG mutant, JOL967, to deliver spike (S) protein 1 of IB virus (V) to elicit protective immunity against both FT and IB in chickens. The codon optimized S1 nucleotide sequence was cloned in-frame into a prokaryotic constitutive expression vector, pJHL65. Subsequently, empty pJHL65 or recombinant pJHL65-S1 plasmid was electroporated into JOL967 and the resultant clones were designated as JOL2068 and JOL2077, respectively. Our results demonstrated that the chickens vaccinated once orally with JOL2077 elicited significantly (p < 0.05) higher IBV-specific humoral and cell-mediated immunity compared to JOL2068 and PBS control groups. Consequently, on challenge with the virulent IBV strain at 28th day post-vaccination, JOL2077 vaccinated birds displayed significantly (p < 0.05) lower inflammatory lesions in virus-targeted tissues compared to control groups. Furthermore, 33.3% (2 of 6) of birds vaccinated with JOL2077 vaccine had shown virus recovery from tracheal tissues compared to 100% (6 of 6) recovery obtained in both the control groups. Against wild-type SG lethal challenge, both JOL2077 and JOL2068 vaccinated groups exhibited only 10% mortality compared to 80% mortality observed in PBS control group. In conclusion, we show that JOL2077 can induce efficient IBV- and carrier-specific protective immunity and can act as a bivalent vaccine against FT and IB. Further studies are warranted to investigate the potential of JOL2077 vaccine in broiler and young layer birds.Electronic supplementary materialThe online version of this article (10.1186/s13567-018-0588-9) contains supplementary material, which is available to authorized users.
机译:禽伤寒(FT)是由沙门氏菌(Salmonella Gallinarum)(SG)引起的败血病和传染性支气管炎(IB)是影响全球禽业的两种经济上重要的禽类疾病。在这里,我们利用活的减毒SG突变体JOL967来传递IB病毒(V)的刺突(S)蛋白1,以引起针对鸡的FT和IB的保护性免疫。将经密码子优化的S1核苷酸序列符合读框地克隆到原核组成型表达载体pJHL65中。随后,将空的pJHL65或重组pJHL65-S1质粒电穿孔到JOL967中,并将所得克隆分别命名为JOL2068和JOL2077。我们的结果表明,与JOL2068和PBS对照组相比,口服JOL2077疫苗的鸡引起的IBV特异性体液免疫和细胞介导的免疫显着提高(p <0.05)。因此,在接种后第28天受到强毒IBV毒株的攻击后,与对照组相比,接种JOL2077的禽鸟在以病毒为靶标的组织中显示出较低的炎性病变(p <0.05)。此外,接种了JOL2077疫苗的禽鸟中33.3%(每6只中的2只)显示出从气管组织中恢复的病毒,而在两个对照组中均获得了100%(每6只中的6只)的恢复。针对野生型SG致死性攻击,接种JOL2077和JOL2068的组均仅显示10%的死亡率,而在PBS对照组中观察到80%的死亡率。总之,我们表明JOL2077可以诱导有效的IBV和载体特异性保护性免疫,并且可以作为针对FT和IB的二价疫苗。有必要进行进一步的研究以调查JOL2077疫苗在肉鸡和雏鸡中的潜力。电子补充材料本文的在线版本(10.1186 / s13567-018-0588-9)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号